Benoît Terris

AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.

J. Zucman‐Rossi, M. Vasseur-Cognet, J. Calderaro, 2018, Journal of hepatology.

Cholestasis is a marker for hepatocellular carcinomas displaying β‐catenin mutations

C. Elie, C. Cavard, G. Grimber, 2007, The Journal of pathology.

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.

L. Rubbia‐Brandt, B. Dousset, P. Majno, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.